Recombinant feline herpesvirus-1 (FHV-1) expressing granulocyte colony-stimulating factor (G-CSF) exhibits enhanced protective efficacy in felines

IF 2.8 3区 医学 Q3 VIROLOGY
Mengfang Yang , Yuzhou Jiao , Yuanyuan Yan , Zhen Fu , Lisha Li , Zirui Liu , Lingying Fang , Xiaoshuai Hu , Benyuan Wu , Yuejun Shi , Mengxia Li , Zhou Shen , Guiqing Peng
{"title":"Recombinant feline herpesvirus-1 (FHV-1) expressing granulocyte colony-stimulating factor (G-CSF) exhibits enhanced protective efficacy in felines","authors":"Mengfang Yang ,&nbsp;Yuzhou Jiao ,&nbsp;Yuanyuan Yan ,&nbsp;Zhen Fu ,&nbsp;Lisha Li ,&nbsp;Zirui Liu ,&nbsp;Lingying Fang ,&nbsp;Xiaoshuai Hu ,&nbsp;Benyuan Wu ,&nbsp;Yuejun Shi ,&nbsp;Mengxia Li ,&nbsp;Zhou Shen ,&nbsp;Guiqing Peng","doi":"10.1016/j.virol.2024.110282","DOIUrl":null,"url":null,"abstract":"<div><div>Vaccine efficacy relies not only on antigens but also on immunomodulatory agents/adjuvants that are often used to stimulate the immune system and enhance the immune response. However, current immunomodulatory agents are used to increase the immune response induced by viral or bacterial inactivated vaccine antigens, bacterial toxoids or polysaccharides but not attenuated live viruses. Based on the immunomodulatory functions of G-CSF and the characteristics of feline herpesvirus-1 (FHV-1) as an expression vector, a recombinant virus expressing feline G-CSF (WH2020-ΔTK/gI/gE-G-CSF) was constructed. The growth dynamics of WH2020-ΔTK/gI/gE-G-CSF were similar to those of WH2020-ΔTK/gI/gE. Compared with kittens vaccinated with WH2020 Δ TK/gI/gE, felines inoculated with WH2020 ΔTK/gI/gE-G-CSF produced more neutralizing antibodies and neutrophils, further alleviating clinical symptoms after FHV-1 infection. Taken together, our results revealed the potential of G-CSF as an ideal immune potentiator that can augment immune responses to FHV-1 and even other attenuated live vaccines.</div></div>","PeriodicalId":23666,"journal":{"name":"Virology","volume":"601 ","pages":"Article 110282"},"PeriodicalIF":2.8000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042682224003064","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Vaccine efficacy relies not only on antigens but also on immunomodulatory agents/adjuvants that are often used to stimulate the immune system and enhance the immune response. However, current immunomodulatory agents are used to increase the immune response induced by viral or bacterial inactivated vaccine antigens, bacterial toxoids or polysaccharides but not attenuated live viruses. Based on the immunomodulatory functions of G-CSF and the characteristics of feline herpesvirus-1 (FHV-1) as an expression vector, a recombinant virus expressing feline G-CSF (WH2020-ΔTK/gI/gE-G-CSF) was constructed. The growth dynamics of WH2020-ΔTK/gI/gE-G-CSF were similar to those of WH2020-ΔTK/gI/gE. Compared with kittens vaccinated with WH2020 Δ TK/gI/gE, felines inoculated with WH2020 ΔTK/gI/gE-G-CSF produced more neutralizing antibodies and neutrophils, further alleviating clinical symptoms after FHV-1 infection. Taken together, our results revealed the potential of G-CSF as an ideal immune potentiator that can augment immune responses to FHV-1 and even other attenuated live vaccines.
表达粒细胞集落刺激因子(G-CSF)的重组猫疱疹病毒-1(FHV-1)在猫科动物中表现出更强的保护效力。
疫苗的疗效不仅取决于抗原,还取决于免疫调节剂/佐剂,它们通常用于刺激免疫系统和增强免疫反应。然而,目前的免疫调节剂用于提高病毒或细菌灭活疫苗抗原、细菌毒素或多糖诱导的免疫反应,而不是减毒活疫苗。根据 G-CSF 的免疫调节功能和猫疱疹病毒-1(FHV-1)作为表达载体的特点,构建了表达猫 G-CSF 的重组病毒(WH2020-ΔTK/gI/gE-G-CSF)。WH2020-ΔTK/gI/gE-G-CSF的生长动态与WH2020-ΔTK/gI/gE相似。与接种WH2020 ΔTK/gI/gE的幼猫相比,接种WH2020 ΔTK/gI/gE-G-CSF的猫产生了更多的中和抗体和中性粒细胞,进一步减轻了FHV-1感染后的临床症状。综上所述,我们的研究结果揭示了 G-CSF 作为一种理想的免疫增强剂的潜力,它可以增强对 FHV-1 甚至其他减毒活疫苗的免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Virology
Virology 医学-病毒学
CiteScore
6.00
自引率
0.00%
发文量
157
审稿时长
50 days
期刊介绍: The journal features articles on virus replication, virus-host biology, viral pathogenesis, immunity to viruses, virus structure, and virus evolution and ecology. We aim to publish papers that provide advances to the understanding of virus biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信